Loading…
CIK 0001813845 • 6 13F filings • May 14, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("bios-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS INC | COM | $61.5M | 74.4%Prev: 75.6% | 10,049,996 SH | Decreased |
| COGNITION THERAPEUTICS INC | COM | $8.1M | 9.8%Prev: 9.1% | 6,000,000 SH | Increased |
| IN8BIO INC | COM NEW | $593K | 0.7% | 253,417 SH | New |
| LANTERN PHARMA INC | COM | $3.1M | 3.7%Prev: 5.0% | 1,009,507 SH | Decreased-6,208 SH |
| OPUS GENETICS INC | COM | $7.4M | 9.0%Prev: 7.4% | 3,683,429 SH | Increased |
| REIN THERAPEUTICS INC | COM NEW | $2.0M | 2.4%Prev: 2.2% | 1,690,751 SH | Increased |
| 13F-HR |
| 0001813845-26-000004 |
| $41.7M |
| View |
| Aug 12, 2025 | Q2 2025 | 13F-HR | 0001104659-25-076893 | $72.6M | View |
| May 13, 2026 | Q1 2026 | 13F-HR | 0001813845-26-000003 | $52.9M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001104659-25-048606 | $79.2M | View |